selected scholarly activity
-
conferences
- A Prospective, Observational Study of Patient-Reported Outcomes in Adult Chronic Migraine Patients Treated with OnabotulinumtoxinA: PREDICT Study Methods and Baseline Data. Headache. 28-28. 2016
- Canadian Headache Society Systematic Review & Recommendations on the Acute Treatment of Migraine Pain in Emergency Settings. Headache. 11-12. 2014
- Over-the-counter medication in migraine: a questionnaire-based analysis in migraineurs in Spain. European Journal of Neurology. 323-323. 2008
- The importance of initial drug choice when treating migraine: a questionnaire-based analysis of migraineurs in Spain. European Journal of Neurology. 323-323. 2008
- Effect of prophylactic treatment with botulinum toxin type a on the cost of acute headache medication and health-related quality of life in patients with chronic migraine. Headache. S49-S50. 2008
- Patient strategies for the management of migraine: Interim results from an online market research study (MAZE study phase IV). European Journal of Neurology. 94-94. 2004
- Clinical characteristics of patients referred to headache specialists in Canada. Cephalalgia. 706-707. 2003
- Oral zolmitriptan exhibits efficacy as early as 30 minutes in menstrually associated migraine: Results of a large multicenter placebo-controlled study. Neurology. A414-A415. 2002
-
journal articles
- A real‐world, observational study of erenumab for migraine prevention in Canadian patients. Headache. 62:522-529. 2022
- Canadian Headache Society systematic review and recommendations on the treatment of migraine pain in emergency settings. Cephalalgia. 35:271-284. 2015
- Botulinum Toxin Type A and Acute Drug Costs in Migraine with Triptan Overuse. Canadian Journal of Neurological Sciences. 37:588-594. 2010
- HIT‐6 and MIDAS as Measures of Headache Disability in a Headache Referral Population. Headache. 50:383-395. 2010
- Moving forward to improve migraine management in Canada.. Canadian Journal of Neurological Sciences. 34:S20-S26. 2007
- A Clinical Study of Migraine Evolution. Headache. 46:1480-1486. 2006
- Demographics and Clinical Features of Patients Referred to Headache Specialists. Canadian Journal of Neurological Sciences. 33:228-234. 2006
- Clinical Features and Pharmacological Treatment of Migraine Patients Referred to Headache Specialists in Canada. Cephalalgia. 26:578-588. 2006
- Migraine treatment strategies: the global Migraine And Zolmitriptan Evaluation (MAZE) survey – phase IV*. Current Medical Research and Opinion. 20:1777-1783. 2004
- Correction to: E. A. MacGregor, J. Brandes, A. Eikermann and R. Giammarco. Impact of migraine on patients and their families: the Migraine And Zolmitriptan Evaluation (MAZE) survey - Phase III. Curr Med Res Opin 2004; 20(7): 1143-1150.. Current Medical Research and Opinion. 20:1689-1690. 2004
- Impact of migraine on patients and their families: the Migraine And Zolmitriptan Evaluation (MAZE) survey – Phase III. Current Medical Research and Opinion. 20:1143-1150. 2004
- Efficacy of Zolmitriptan at Early Time-Points for the Acute Treatment of Migraine and Treatment of Recurrence. CNS Drugs. 13:215-226. 2000
- Plasma exchange in chronic inflammatory demyelinating polyneuropathies. Transfusion and Apheresis Science. 17:415-422. 1996